Anticaries protocol
This article was originally published in The Rose Sheet
Executive Summary
CTFA requests FDA confirm that "contemporary" protocols are compliant with the biological testing of anticaries drug products accepted in the final monograph. The Dec. 14 request, which was submitted jointly by CTFA and the Consumer Healthcare Products Association, answers technical questions asked by the agency in an April 30, 1999 "feedback" letter regarding the three existing methods of protocol: animal caries reduction, enamel solubility reduction and enamel fluoride uptake. The issue was the subject of an OTC "feedback" meeting April 12 (1"The Rose Sheet" April 19, 1999, p. 10). The trade groups note a working group meeting may be needed to resolve outstanding questions
You may also be interested in...
Anticaries Contemporary Protocols Recognition By FDA Sought By CTFA/CHPA
The Cosmetic, Toiletry and Fragrance Association and the Consumer Healthcare Products Association are seeking FDA approval of procedural variations to three existing anticaries final formulation testing protocols. The request was the subject of an OTC "feedback" meeting in Rockville, Md. April 12.
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle